Valsartan en syn intermediates

  • Valsartan 137862-53-4

    Valsartan 137862-53-4

    Profesjonele manufacturing en oanbod biopharmaceutical |Chemical Reagents |Gemyske grûnstoffen |Yndustriële farmaseutyske tuskenlizzende |Cardiovascular |Hypertensie behanneling |Valsartan Intermediates |Valsartan |CAS:137862-53-4 |C24H29N5O3

  • L-Valine methylester hydrochloride 6306-52-1

    L-Valine methylester hydrochloride 6306-52-1

    Profesjonele manufacturing en oanbod biopharmaceutical |Chemical Reagents |Gemyske grûnstoffen |Yndustriële farmaseutyske tuskenlizzende |Cardiovascular |Valsartan Intermediates |L-Valine methylester hydrochloride |CAS: 6306-52-1 |C6H13NO2.HCl

  • N-[(2'-cyano[1,1'-bifenyl]-4-yl)methyl]-L-valine methylester hydrochloride 482577-59-3

    N-[(2'-cyano[1,1'-bifenyl]-4-yl)methyl]-L-valine methylester hydrochloride 482577-59-3

    Profesjonele manufacturing en oanbod biopharmaceutical |Chemical Reagents |Gemyske grûnstoffen |Yndustriële farmaseutyske tuskenlizzende |Cardiovascular |Hypertensie behanneling |Valsartan Intermediates |N-[(2'-Cyano[1,1'-bifenyl]-4-yl)methyl]-L-valinemethylesterhydrochloride |CAS: 482577-59-3 |C20H22N2O2.HCl

  • Valsartan methylester 137863-17-3

    Valsartan methylester 137863-17-3

    Profesjonele manufacturing en oanbod biopharmaceutical |Chemical Reagents |Gemyske grûnstoffen |Yndustriële farmaseutyske tuskenlizzende |Cardiovascular |Hypertensie behanneling |Valsartan Intermediates |N-(1-Oxopentyl)-N-[[2'-(1H-tetrazol-5-yl)[1,1'-bifenyl]-4-yl]methyl]-L-valinemethylester |CAS:137863-17-3 |C25H31N5O3